Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

MDxHealth (MDXH) Net Margin: 2019-2024

Historic Net Margin for MDxHealth (MDXH) over the last 6 years, with Dec 2024 value amounting to 42.28%.

  • MDxHealth's Net Margin rose 1584.00% to 29.24% in Q3 2025 from the same period last year, while for Sep 2025 it was 30.15%, marking a year-over-year increase of 1857.00%. This contributed to the annual value of 42.28% for FY2024, which is 1913.00% up from last year.
  • Per MDxHealth's latest filing, its Net Margin stood at 42.28% for FY2024, which was up 31.15% from 61.40% recorded in FY2023.
  • MDxHealth's Net Margin's 5-year high stood at 42.28% during FY2024, with a 5-year trough of 155.27% in FY2020.
  • In the last 3 years, MDxHealth's Net Margin had a median value of 61.40% in 2023 and averaged 74.18%.
  • Its Net Margin has fluctuated over the past 5 years, first skyrocketed by 21,045bps in 2020, then plummeted by 1,155bps in 2022.
  • MDxHealth's Net Margin (MRY) stood at 155.27% in 2020, then grew by 16bps to 130.41% in 2021, then increased by 9bps to 118.86% in 2022, then skyrocketed by 48bps to 61.40% in 2023, then soared by 31bps to 42.28% in 2024.
  • Its Net Margin stands at 42.28% for FY2024, versus 61.40% for FY2023 and 118.86% for FY2022.